Displaying drugs 12301 - 12325 of 12696 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Uttroside B | 1215.34 C56H94O28 |  | Not Annotated | Not Annotated |
| Uzansertib | Not Annotated |  | Uzansertib is under investigation in clinical trial NCT02587598 (Study of INCB053914 in Subjects With Advanced Malignancies). | Not Annotated |
| V1003 | Not Available |  | Investigated for use/treatment in pain (acute or chronic). | Not Available |
| V116517 | 442.82 C19H18ClF3N4O3 |  | V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)). | Amines / Pyridines |
| V24343 | Not Available |  | Obesity related disorders such as cardiovascular disease and type II diabetes | Not Available |
| Vabicaserin | 228.339 C15H20N2 |  | Vabicaserin has been used in trials studying the health services research and treatment of Schizophrenia. | Antidepressive Agents / Central Nervous System Depressants / Heterocyclic Compounds, Fused-Ring / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome / Serotonin 5-HT2 Receptor Agonists / Serotonin 5-HT2C Receptor Agonists / Serotonin Agents / Serotonin Receptor Agonists |
| Vaborbactam | 297.13 C12H16BNO5S |  | A beta lactamase inhibitor used to treat complicated urinary tract infections. | beta-Lactamase Inhibitors |
| Vactosertib | 399.433 C22H18FN7 |  | Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer). | Protein Kinase Inhibitors |
| VAD-044 | Not Annotated |  | VAD-044 is an allosteric AKT inhibitor developed by Vaderis Therapeutics AG. It is being investigated for the treatment of Hereditary Hemorrhagic Telangiectasia. | Not Annotated |
| Vadadustat | 306.7 C14H11ClN2O4 |  | An oral hypoxia-inducible factor prolyl-hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis. | Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Erythropoiesis-Stimulating Agents / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT3/SLC22A8 Inhibitors / OAT3/SLC22A8 Substrates / Pyridines / UGT1A1 Inducers / UGT1A1 Substrates / UGT1A9 Substrates / UGT2B7 substrates |
| Vadimezan | 282.2907 C17H14O4 |  | Investigated for use/treatment in solid tumors, lung cancer, ovarian cancer, and prostate cancer. | Antineoplastic Agents |
| Vafidemstat | 336.395 C19H20N4O2 |  | Vafidemstat is under investigation in clinical trial NCT03867253 (Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease). | Oxazoles |
| Valaciclovir | 324.3357 C13H20N6O4 |  | An guanine nucleoside antiviral used to treat herpes exacerbations. | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Valbenazine | 418.578 C24H38N2O4 |  | A vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia and chorea associated with Huntington's disease. | Vesicular Monoamine Transporter 2 Inhibitor |
| Valdecoxib | 314.359 C16H14N2O3S |  | A COX-2 inhibitor used to treat osteoarthritis and dysmenorrhoea. | COX-2 Inhibitors / Selective Cyclooxygenase 2 Inhibitors (NSAIDs) |
| Valemetostat | 488.03 C26H34ClN3O4 |  | Not Annotated | Not Annotated |
| Valethamate | 306.469 C19H32NO2 |  | An anticholinergic medication used to symptomatically manage conditions involving smooth muscle spasms including spastic constipation, dysmenorrhea, and gastrointestinal tract cramping. | Alimentary Tract and Metabolism / Amines / Ammonium Compounds / Drugs for Functional Gastrointestinal Disorders / Nitrogen Compounds / Onium Compounds |
| Valganciclovir | 354.3617 C14H22N6O5 |  | An antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS). | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Valiloxibic acid | 203.238 C9H17NO4 |  | Not Annotated | Not Annotated |
| Valine | 117.1463 C5H11NO2 |  | An amino acid commonly found as a component of total parenteral nutrition. | Amino Acids, Branched-Chain / Amino Acids, Essential |
| Valine-valine-ganciclovir | 453.5 C19H31N7O6 |  | Not Available | Not Available |
| Valinomycin | 1111.338 C54H90N6O18 |  | A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately... | Anti-Bacterial Agents / Depsipeptides / Ionophores |
| Valnoctamide | 143.23 C8H17NO |  | Valnoctamide has been used in trials studying the treatment of Mania and Schizoaffective Disorder, Manic Type. | Central Nervous System Depressants / Hypnotics and Sedatives / Nervous System / Psycholeptics |
| Valomaciclovir | 352.395 C15H24N6O4 |  | Investigated for use/treatment in herpes zoster infections and viral infection. | Herpes Zoster |
| Valomaciclovir stearate | 618.864 C33H58N6O5 |  | Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster). | Herpes Zoster |
Displaying drugs 12301 - 12325 of 12696 in total